Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

An asymptotic hyperbolic-elliptic model for flexural-seismic metasurfaces.

Wootton PT, Kaplunov J, Colquitt DJ.

Proc Math Phys Eng Sci. 2019 Jul;475(2227):20190079. doi: 10.1098/rspa.2019.0079. Epub 2019 Jul 24.

PMID:
31423092
2.

Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study.

Wootton PT, Arora NL, Drenos F, Thompson SR, Cooper JA, Stephens JW, Hurel SJ, Hurt-Camejo E, Wiklund O, Humphries SE, Talmud PJ.

Hum Mol Genet. 2007 Jun 15;16(12):1437-44.

PMID:
17545304
3.

Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training.

Wootton PT, Flavell DM, Montgomery HE, World M, Humphries SE, Talmud PJ.

Nutr Metab Cardiovasc Dis. 2007 Jan;17(1):24-31. Epub 2006 Mar 20.

PMID:
17174223
4.

Functional proteomics of BK potassium channels: defining the acute oxygen sensor.

Kemp PJ, Williams SE, Mason HS, Wootton P, Iles DE, Riccardi D, Peers C.

Novartis Found Symp. 2006;272:141-51; discussion 151-6, 214-7. Review.

PMID:
16686434
5.

In search of the acute oxygen sensor: functional proteomics and acute regulation of large-conductance, calcium-activated potassium channels by hemeoxygenase-2.

Kemp PJ, Peers C, Riccardi L, Iles DE, Mason HS, Wootton P, Williams SE.

Adv Exp Med Biol. 2006;580:137-46; discussion 351-9. No abstract available.

PMID:
16683710
6.

Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus.

Wootton PT, Stephens JW, Hurel SJ, Durand H, Cooper J, Ninio E, Humphries SE, Talmud PJ.

Atherosclerosis. 2006 Nov;189(1):149-56. Epub 2006 Jan 24.

PMID:
16438975
7.

Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth.

Flavell DM, Wootton PT, Myerson SG, World MJ, Pennell DJ, Humphries SE, Talmud PJ, Montgomery HE.

J Mol Med (Berl). 2006 Feb;84(2):126-31. Epub 2006 Jan 17.

PMID:
16416313
8.

Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study.

Wootton PT, Drenos F, Cooper JA, Thompson SR, Stephens JW, Hurt-Camejo E, Wiklund O, Humphries SE, Talmud PJ.

Hum Mol Genet. 2006 Jan 15;15(2):355-61. Epub 2005 Dec 20.

PMID:
16368710
9.

Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel.

Williams SE, Wootton P, Mason HS, Bould J, Iles DE, Riccardi D, Peers C, Kemp PJ.

Science. 2004 Dec 17;306(5704):2093-7. Epub 2004 Nov 4.

10.

siRNA knock-down of gamma-glutamyl transpeptidase does not affect hypoxic K+ channel inhibition.

Williams SE, Wootton P, Mason HS, Iles DE, Peers C, Kemp PJ.

Biochem Biophys Res Commun. 2004 Jan 30;314(1):63-8.

PMID:
14715246
11.

Bradykinin receptor gene variant and human physical performance.

Williams AG, Dhamrait SS, Wootton PT, Day SH, Hawe E, Payne JR, Myerson SG, World M, Budgett R, Humphries SE, Montgomery HE.

J Appl Physiol (1985). 2004 Mar;96(3):938-42. Epub 2003 Nov 7.

12.

Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension.

Dhamrait SS, Payne JR, Li P, Jones A, Toor IS, Cooper JA, Hawe E, Palmen JM, Wootton PT, Miller GJ, Humphries SE, Montgomery HE.

Eur Heart J. 2003 Sep;24(18):1672-80.

PMID:
14499231
13.

Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension.

Jones A, Dhamrait SS, Payne JR, Hawe E, Li P, Toor IS, Luong L, Wootton PT, Miller GJ, Humphries SE, Montgomery HE.

Hypertension. 2003 Oct;42(4):500-6. Epub 2003 Aug 18.

PMID:
12925562
14.

Acute oxygen sensing in cellular models: relevance to the physiology of pulmonary neuroepithelial and carotid bodies.

Kemp PJ, Searle GJ, Hartness ME, Lewis A, Miller P, Williams S, Wootton P, Adriaensen D, Peers C.

Anat Rec A Discov Mol Cell Evol Biol. 2003 Jan;270(1):41-50. Review.

15.

AMA supports collective voice, but not pickets.

Wootton P.

Mod Healthc. 1998 May 11;28(19):64. No abstract available.

PMID:
10180463
16.

The American Medical Association, the Federation, and the road ahead.

Wootton P.

Arthroscopy. 1998 Sep;14(6):653-5. No abstract available.

PMID:
9840947
17.

Two chairs and beyond: protecting our patients and our medical profession.

Wootton P.

Va Med Q. 1997 Summer;124(3):170-3. No abstract available.

PMID:
9227045
18.

It takes a revolution. Restoring the balance in health care.

Wootton P.

J Okla State Med Assoc. 1997 May-Jun;90(5):191-4. No abstract available.

PMID:
9203768
19.

Boron neutron capture enhanced fast neutron radiotherapy for malignant gliomas and other tumors.

Buchholz TA, Laramore GE, Stelzer KJ, Risler R, Wootton P, Griffin TW.

J Neurooncol. 1997 May;33(1-2):171-8. Review.

PMID:
9151234
20.

Integration of radiotherapy planning systems and radiotherapy treatment equipment: 11 years experience.

Kalet IJ, Jacky JP, Risler R, Rohlin S, Wootton P.

Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):213-21.

PMID:
9212026
21.

Fast neutron radiotherapy and boron neutron capture therapy: application to a human melanoma test system.

Laramore GE, Risler R, Griffin TW, Wootton P, Wilbur DS.

Bull Cancer Radiother. 1996;83 Suppl:191s-7s.

PMID:
8949778
22.

Impact of a multileaf collimator on treatment morbidity in localized carcinoma of the prostate.

Austin-Seymour M, Caplan R, Russell K, Laramore G, Jacky J, Wootton P, Hummel S, Lindsley K, Griffin T.

Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1065-71.

PMID:
7961013
23.

Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy.

Laramore GE, Wootton P, Livesey JC, Wilbur DS, Risler R, Phillips M, Jacky J, Buchholz TA, Griffin TW, Brossard S.

Int J Radiat Oncol Biol Phys. 1994 Mar 30;28(5):1135-42.

PMID:
8175398
24.

Enhancement of fast neutron beams with boron neutron capture therapy. A mechanism for achieving a selective, concomitant tumor boost.

Buchholz TA, Laramore GE, Wootton P, Livesey JC, Wilbur DS, Risler R, Phillips M, Jacky J, Griffin TW.

Acta Oncol. 1994;33(3):307-13.

PMID:
8018360
25.

Nervous ketosis.

Wootton P.

Can Vet J. 1992 Mar;33(3):194. No abstract available.

27.

Rodent model of chemoradiotherapy-induced white matter necrosis.

Taylor EM, Geyer JR, Milstein JM, Shaw CM, Geraci JP, Wootton P, Hubbard BA, Bleyer WA.

NCI Monogr. 1988;(6):59-64.

PMID:
3352790
28.

The effects of intracisternal thyrotropin releasing hormone (TRH) on gastroduodenal motility in the rat.

Davison JS, Wootton P, Hickie J.

Proc West Pharmacol Soc. 1988;31:25-7. No abstract available.

PMID:
3145502
29.

Uniformity in dosimetry protocols for therapeutic applications of fast neutron beams.

Mijnheer BJ, Wootton P, Williams JR, Eenmaa J, Parnell CJ.

Med Phys. 1987 Nov-Dec;14(6):1020-6.

PMID:
3696066
30.

The responsibilities of a physician.

Wootton P.

Va Med. 1987 Aug;114(8):481-2. No abstract available.

PMID:
3660929
31.

Neutron beam characteristics from 50 MeV protons on beryllium using a continuously variable multi-leaf collimator.

Brahme A, Eenmaa J, Lindb├Ąck S, Montelius A, Wootton P.

Radiother Oncol. 1983 Aug;1(1):65-76.

PMID:
6438702
32.

Systemic changes in burn injury.

Wootton P.

Nurs Times. 1981 Dec 2-8;77(49):2093-9. No abstract available.

PMID:
6915508
33.

Presidential address: Dr. Wootton commends and recommends.

Wootton P.

Va Med. 1981 Dec;108(12):792-5. No abstract available.

PMID:
7336826
34.

Treatment planning procedures at the University of Washington.

Eenmaa J, Wootton P, Kalet I.

Strahlentherapie Sonderb. 1981;77:199-207. No abstract available.

PMID:
6820998
35.

Dosimetric properties of neutrons from 21-MeV deuteron bombardment of a deuterium gas target.

Weaver KA, Eenmaa J, Bichsel H, Wootton P.

Med Phys. 1979 May-Jun;6(3):193-6.

PMID:
112370
36.

Correction factors for neutron dose changes caused by inhomogeneities.

Weaver KA, Eenmaa J, Wootton P.

Med Phys. 1979 Jan-Feb;6(1):21-5. No abstract available.

PMID:
440227
37.

Measurement of photon dose fraction in a neutron radiotherapy beam.

Weaver K, Bichsel H, Eenmaa J, Wootton P.

Med Phys. 1977 Sep-Oct;4(5):376-86.

PMID:
409918
38.

Treatment planning for neutron radiation therapy.

Wootton P, Weaver K, Eenmaa J.

Int J Radiat Oncol Biol Phys. 1977;3:177-83. No abstract available.

PMID:
96051
39.
40.

Fast neutron beam radiotherapy at the University of Washington.

Wootton P, Alvar K, Bichsel H, Eenmaa J, Nelson JR, Parker RG, Weaver KA, Williams DL, Wyckoff WG.

J Can Assoc Radiol. 1975 Mar;26(1):44-53. No abstract available.

PMID:
167027
41.

Fast neutron beam dosimetry: comparison of the ion chamber and proportional counter approaches.

Bichsel H, Eenmaa J, Schumacher DR, Weaver KA, Williams DL, Wootton P, Wyckoff WG.

Eur J Cancer. 1974 May;10(5):315-6. No abstract available.

PMID:
4216488
42.

The University of Washington fast neutron beam therapy facility.

Wootton P, Bichsel H, Eenmaa J, Weaver KA, Williams DL, Wyckoff WG.

Eur J Cancer. 1974 Apr;10(4):265-6. No abstract available.

PMID:
4216477
43.

The efficoency of gonadal shields.

Lambdin DL, Wootton P.

Phys Med Biol. 1969 Apr;14(2):341. No abstract available.

PMID:
5777134
44.

Human skin response to radiation therapy with high-pressure oxygen at 30 p.s.i.g.

Parker RG, Wootton P, Rowe JW.

Am J Roentgenol Radium Ther Nucl Med. 1967 Aug;100(4):920-3. No abstract available.

PMID:
4951458
45.

Single dose erythemas of skin in hyperbaric radiation therapy.

Parker RG, Wootton P.

Radiol Clin Biol. 1967;36(1):24-6. No abstract available.

PMID:
6030091
46.

Treatment fractionation in new radiation therapy modalities.

Wootton P.

Am J Roentgenol Radium Ther Nucl Med. 1966 Apr;96(4):871-6. No abstract available.

PMID:
5935477
47.

RADIATION CATARACT IN CLINICAL THERAPEUTIC RADIOLOGY.

PARKER RG, BURNETT LL, WOOTTON P, MCINTYRE DJ.

Radiology. 1964 May;82:794-9. No abstract available.

PMID:
14153669
48.

DOSAGE TO IMPORTANT SITES IN RADIATION THERAPY OF TUMORS ABOUT THE HEAD AND NECK.

PARKER RG, WOOTTON P, BURNETT L.

Am J Roentgenol Radium Ther Nucl Med. 1963 Aug;90:240-5. No abstract available.

PMID:
14048117
49.

Acute massive hepatic necrosis with fatal liver failure.

CARAVATI CM, WOOTTON P.

South Med J. 1962 Dec;55:1268-77. No abstract available.

PMID:
14018518
50.

Oxygen as a radiotherapeutic adjuvant.

WOOTTON P.

Prog Radiat Ther. 1962;2:94-113. No abstract available.

PMID:
14008306

Supplemental Content

Loading ...
Support Center